JP2021502347A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2021502347A5 JP2021502347A5 JP2020524573A JP2020524573A JP2021502347A5 JP 2021502347 A5 JP2021502347 A5 JP 2021502347A5 JP 2020524573 A JP2020524573 A JP 2020524573A JP 2020524573 A JP2020524573 A JP 2020524573A JP 2021502347 A5 JP2021502347 A5 JP 2021502347A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- period
- individual
- gemcitabine
- composition according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000008194 pharmaceutical composition Substances 0.000 claims 50
- SDUQYLNIPVEERB-QPPQHZFASA-N gemcitabine Chemical compound O=C1N=C(N)C=CN1[C@H]1C(F)(F)[C@H](O)[C@@H](CO)O1 SDUQYLNIPVEERB-QPPQHZFASA-N 0.000 claims 22
- 229960005277 gemcitabine Drugs 0.000 claims 22
- 238000012423 maintenance Methods 0.000 claims 16
- 206010005003 Bladder cancer Diseases 0.000 claims 8
- 208000007097 Urinary Bladder Neoplasms Diseases 0.000 claims 6
- 201000005112 urinary bladder cancer Diseases 0.000 claims 6
- 238000009115 maintenance therapy Methods 0.000 claims 5
- 210000003205 muscle Anatomy 0.000 claims 4
- 238000002560 therapeutic procedure Methods 0.000 claims 4
- 206010044412 transitional cell carcinoma Diseases 0.000 claims 3
- 210000000626 ureter Anatomy 0.000 claims 3
- 210000002700 urine Anatomy 0.000 claims 3
- 208000023747 urothelial carcinoma Diseases 0.000 claims 3
- 238000002512 chemotherapy Methods 0.000 claims 2
- DQLATGHUWYMOKM-UHFFFAOYSA-L cisplatin Chemical compound N[Pt](N)(Cl)Cl DQLATGHUWYMOKM-UHFFFAOYSA-L 0.000 claims 2
- 229960004316 cisplatin Drugs 0.000 claims 2
- 230000003387 muscular Effects 0.000 claims 2
- 239000000203 mixture Substances 0.000 claims 1
- 238000004321 preservation Methods 0.000 claims 1
- 238000011200 topical administration Methods 0.000 claims 1
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2023173773A JP2024009888A (ja) | 2017-11-08 | 2023-10-05 | ゲムシタビンを使用した膀胱癌の治療及び維持療法の方法 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762583394P | 2017-11-08 | 2017-11-08 | |
| US62/583,394 | 2017-11-08 | ||
| PCT/US2018/059698 WO2019094517A1 (en) | 2017-11-08 | 2018-11-07 | Methods of treatment and maintenance therapy for bladder cancer using gemcitabine |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023173773A Division JP2024009888A (ja) | 2017-11-08 | 2023-10-05 | ゲムシタビンを使用した膀胱癌の治療及び維持療法の方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2021502347A JP2021502347A (ja) | 2021-01-28 |
| JP2021502347A5 true JP2021502347A5 (https=) | 2022-01-04 |
Family
ID=66439297
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020524573A Pending JP2021502347A (ja) | 2017-11-08 | 2018-11-07 | ゲムシタビンを使用した膀胱癌の治療及び維持療法の方法 |
| JP2023173773A Pending JP2024009888A (ja) | 2017-11-08 | 2023-10-05 | ゲムシタビンを使用した膀胱癌の治療及び維持療法の方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023173773A Pending JP2024009888A (ja) | 2017-11-08 | 2023-10-05 | ゲムシタビンを使用した膀胱癌の治療及び維持療法の方法 |
Country Status (18)
| Country | Link |
|---|---|
| US (3) | US10792297B2 (https=) |
| EP (1) | EP3706763A4 (https=) |
| JP (2) | JP2021502347A (https=) |
| KR (3) | KR102892737B1 (https=) |
| CN (1) | CN111787926A (https=) |
| AU (1) | AU2018366106B2 (https=) |
| BR (1) | BR112020008700A2 (https=) |
| CA (1) | CA3081839A1 (https=) |
| DO (1) | DOP2023000155A (https=) |
| EA (1) | EA202091143A1 (https=) |
| IL (2) | IL302714B1 (https=) |
| JO (1) | JOP20200124A1 (https=) |
| MA (1) | MA50581A (https=) |
| MX (2) | MX2020004771A (https=) |
| PE (1) | PE20210041A1 (https=) |
| PH (1) | PH12020550587A1 (https=) |
| SG (1) | SG11202003950WA (https=) |
| WO (1) | WO2019094517A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20150250717A1 (en) | 2014-03-06 | 2015-09-10 | Taris Biomedical Llc | Drug delivery systems and methods for treatment of bladder cancer with gemcitabine |
| SG10201913998YA (en) | 2017-07-25 | 2020-03-30 | Taris Biomedical Llc | Methods of treating tumor metastasis |
| IL302714B1 (en) * | 2017-11-08 | 2026-01-01 | Taris Biomedical Llc | Methods for treating and maintaining bladder cancer using gemcitabine |
| WO2024092159A1 (en) * | 2022-10-28 | 2024-05-02 | Taris Biomedical Llc | Methods of treating bladder cancer with gemcitabine |
Family Cites Families (49)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4008719A (en) | 1976-02-02 | 1977-02-22 | Alza Corporation | Osmotic system having laminar arrangement for programming delivery of active agent |
| US4111203A (en) | 1976-11-22 | 1978-09-05 | Alza Corporation | Osmotic system with means for improving delivery kinetics of system |
| US6171298B1 (en) | 1996-05-03 | 2001-01-09 | Situs Corporation | Intravesical infuser |
| WO2009139984A2 (en) | 2008-04-04 | 2009-11-19 | Lipella Pharmaceuticals, Inc. | Method of treatment for bladder dysfunction |
| AU2003278881A1 (en) | 2002-09-23 | 2004-04-08 | Microchips, Inc. | Micro-reservoir osmotic release systems and microtube array device |
| US20040260272A1 (en) | 2002-10-22 | 2004-12-23 | Friedman Craig D. | Method and system for intravesicular delivery of therapeutic agents |
| US8361490B2 (en) | 2004-09-16 | 2013-01-29 | Theracoat Ltd. | Biocompatible drug delivery apparatus and methods |
| JP5265359B2 (ja) | 2005-08-11 | 2013-08-14 | マサチューセッツ インスティテュート オブ テクノロジー | 膀胱内薬物送達デバイスおよび方法 |
| EP2012801A4 (en) | 2006-04-24 | 2009-08-05 | Gloucester Pharmaceuticals Inc | GEMCITABINE COMBINATION THERAPY |
| EP1913962A1 (en) | 2006-10-22 | 2008-04-23 | Ophir Perelson | Expandable medical device for the treatment and prevention of cardiovascular diseases |
| US9586035B2 (en) | 2007-12-11 | 2017-03-07 | Massachusetts Institute Of Technology | Implantable drug delivery device and methods for treatment of the bladder and other body vesicles or lumens |
| JP2011528275A (ja) | 2008-07-17 | 2011-11-17 | ミセル テクノロジーズ，インク． | 薬物送達医療デバイス |
| EA201170297A1 (ru) | 2008-08-09 | 2011-08-30 | Массачусетс Инститьют Оф Текнолоджи | Имплантируемое устройство для доставки лекарственных средств и способ лечения мужской мочеполовой системы и окружающих тканей |
| CN102470237A (zh) | 2009-06-26 | 2012-05-23 | 塔里斯生物医药公司 | 用于可植入药物递送装置的固体药物片剂 |
| US8721621B2 (en) | 2009-09-10 | 2014-05-13 | Taris Biomedical, Inc. | Systems and methods for deploying devices to genitourinary sites |
| US9017312B2 (en) | 2009-09-10 | 2015-04-28 | Taris Biomedical Llc | Implantable device for controlled drug delivery |
| PL3884988T3 (pl) | 2009-12-17 | 2025-09-08 | Taris Biomedical Llc | Urządzenie implantowalne z tolerancją wewnątrzpęcherzową |
| WO2011089604A2 (en) | 2010-01-20 | 2011-07-28 | Theracoat Ltd | Material and method for treating internal cavities |
| US20110218488A1 (en) | 2010-03-05 | 2011-09-08 | Taris Biomedical, Inc. | Systems and Methods for Implanting Devices in the Bladder and Other Genitourinary Sites |
| CA2801314A1 (en) | 2010-06-02 | 2011-12-08 | Abraxis Bioscience, Llc | Methods of treating bladder cancer |
| DK2600800T3 (da) | 2010-08-05 | 2020-11-16 | Taris Biomedical Llc | Indretning til lægemiddellevering i en ureterstent og kit dertil |
| US9457176B2 (en) | 2010-10-06 | 2016-10-04 | Taris Biomedical Llc | Implantable drug delivery device with bladder retention feature |
| JP5945544B2 (ja) | 2010-10-06 | 2016-07-05 | タリス バイオメディカル エルエルシー | 時間選択的に生体吸収可能または崩壊可能な薬剤送達システムおよび方法 |
| CN105997967B (zh) | 2010-10-27 | 2019-08-23 | 普罗米蒂克医药Smt有限公司 | 用于治疗癌症的化合物和组合物 |
| WO2012079083A2 (en) | 2010-12-10 | 2012-06-14 | The Board Of Regents Of The University Of Nebraska | Hemodialysis catheter with displaceable tubes to disrupt a fibrous sheath |
| US8979797B2 (en) | 2010-12-16 | 2015-03-17 | Ams Research Corporation | High pressure delivery system and method for treating pelvic disorder using large molecule therapeutics |
| US9114111B2 (en) | 2011-01-10 | 2015-08-25 | Allergan, Inc. | Methods for sustained treatment of bladder pain and irritative voiding |
| AU2012211960B2 (en) | 2011-02-04 | 2016-12-01 | Taris Biomedical Llc | Implantable device for controlled release of low solubility drug |
| US20150005595A1 (en) | 2011-12-30 | 2015-01-01 | Kibur Medical, Inc. | Implantable devices and methods for evaluation of active agents |
| JP6639228B2 (ja) | 2012-03-29 | 2020-02-05 | アルター・バイオサイエンス・コーポレーション | 新生物を治療するための方法 |
| WO2013170069A1 (en) | 2012-05-09 | 2013-11-14 | Massachusetts Institute Of Technology | Medicament, method, and drug delivery device for treatment of ovarian cancer |
| JP6463266B2 (ja) | 2012-08-31 | 2019-01-30 | タリス バイオメディカル エルエルシー | 膀胱癌の治療のためのオキサリプラチンを含む薬物送達システム及び方法 |
| AU2013308465B2 (en) | 2012-08-31 | 2018-05-17 | Taris Biomedical Llc | Drug delivery systems and methods for treatment of prostate disease comprising gemicitabine |
| EP2964310A1 (en) | 2013-03-05 | 2016-01-13 | TARIS Biomedical LLC | Drug delivery devices and methods for controlled drug release through device orifice |
| JP6697376B2 (ja) | 2013-03-15 | 2020-05-20 | タリス バイオメディカル エルエルシー | 薬物送達のための薬物送達装置及び方法 |
| PT2968880T (pt) | 2013-03-15 | 2025-07-07 | Taris Biomedical Llc | Dispositivos de aplicação de fármaco com componente permeável a fármaco |
| WO2014169137A1 (en) | 2013-04-10 | 2014-10-16 | Massachusetts Institute Of Technology | Local drug delivery devices and methods for treating cancer |
| DE102013103986A1 (de) | 2013-04-19 | 2014-10-23 | B. Braun Avitum Ag | Rezirkulationsvorrichtung eines extrakorporalen Blutbehandlungsgeräts |
| CN113413393B (zh) | 2013-08-19 | 2025-03-04 | 塔里斯生物医药公司 | 多单元药物递送装置和方法 |
| US9215250B2 (en) | 2013-08-20 | 2015-12-15 | Janus Technologies, Inc. | System and method for remotely managing security and configuration of compute devices |
| BR112016010103A8 (pt) | 2013-11-05 | 2018-01-30 | Taris Biomedical Llc | métodos, kits e dispositivos de suprimento de fármaco osmótico. |
| US20150250717A1 (en) * | 2014-03-06 | 2015-09-10 | Taris Biomedical Llc | Drug delivery systems and methods for treatment of bladder cancer with gemcitabine |
| RU2591946C2 (ru) | 2014-06-24 | 2016-07-20 | Владимир Эдуардович Анников | Способ изготовления гелеобразного водосодержащего взрывчатого состава |
| JP6856380B2 (ja) | 2014-06-26 | 2021-04-07 | タリス バイオメディカル エルエルシー | 弾性ポリマー−薬物マトリックス系を含む膀胱内薬物送達デバイス及び方法 |
| KR102658706B1 (ko) | 2015-04-23 | 2024-04-17 | 타리스 바이오메디컬 엘엘씨 | 약물-투과성 성분을 구비한 약물 전달 장치 및 방법 |
| CN118453872A (zh) | 2016-05-06 | 2024-08-09 | 塔里斯生物医药公司 | 治疗下尿路尿道上皮癌的方法 |
| SG10201913998YA (en) | 2017-07-25 | 2020-03-30 | Taris Biomedical Llc | Methods of treating tumor metastasis |
| IL302714B1 (en) * | 2017-11-08 | 2026-01-01 | Taris Biomedical Llc | Methods for treating and maintaining bladder cancer using gemcitabine |
| CN112839653A (zh) | 2018-08-01 | 2021-05-25 | 塔里斯生物医药公司 | 使用曲司氯铵治疗膀胱过度活动症的方法 |
-
2018
- 2018-11-07 IL IL302714A patent/IL302714B1/en unknown
- 2018-11-07 EA EA202091143A patent/EA202091143A1/ru unknown
- 2018-11-07 KR KR1020247025280A patent/KR102892737B1/ko active Active
- 2018-11-07 WO PCT/US2018/059698 patent/WO2019094517A1/en not_active Ceased
- 2018-11-07 CN CN201880084854.9A patent/CN111787926A/zh active Pending
- 2018-11-07 SG SG11202003950WA patent/SG11202003950WA/en unknown
- 2018-11-07 KR KR1020207016209A patent/KR20200085822A/ko not_active Ceased
- 2018-11-07 AU AU2018366106A patent/AU2018366106B2/en active Active
- 2018-11-07 KR KR1020257039507A patent/KR20250174098A/ko active Pending
- 2018-11-07 US US16/183,673 patent/US10792297B2/en active Active
- 2018-11-07 MA MA050581A patent/MA50581A/fr unknown
- 2018-11-07 CA CA3081839A patent/CA3081839A1/en active Pending
- 2018-11-07 MX MX2020004771A patent/MX2020004771A/es unknown
- 2018-11-07 JP JP2020524573A patent/JP2021502347A/ja active Pending
- 2018-11-07 IL IL274343A patent/IL274343B2/en unknown
- 2018-11-07 EP EP18875446.9A patent/EP3706763A4/en active Pending
- 2018-11-07 JO JOP/2020/0124A patent/JOP20200124A1/ar unknown
- 2018-11-07 PE PE2020000538A patent/PE20210041A1/es unknown
- 2018-11-07 BR BR112020008700-9A patent/BR112020008700A2/pt unknown
-
2020
- 2020-05-08 PH PH12020550587A patent/PH12020550587A1/en unknown
- 2020-07-13 MX MX2023007680A patent/MX2023007680A/es unknown
- 2020-09-02 US US17/010,648 patent/US12029749B2/en active Active
-
2023
- 2023-03-09 US US18/181,467 patent/US20230321129A1/en active Pending
- 2023-08-04 DO DO2023000155A patent/DOP2023000155A/es unknown
- 2023-10-05 JP JP2023173773A patent/JP2024009888A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021502347A5 (https=) | ||
| JP2024015120A5 (https=) | ||
| JP2019536805A5 (https=) | ||
| JP2021512121A5 (https=) | ||
| IL320452A (en) | Combination therapy for prostate cancer | |
| JP2012506448A5 (https=) | ||
| RU2012106620A (ru) | Комбинации и способы введения терапевтических средств и комбинированной терапии | |
| JP2020516646A5 (https=) | ||
| JP2016530280A5 (https=) | ||
| JP2012067116A5 (https=) | ||
| JP2012509889A5 (https=) | ||
| ME02395B (me) | Kombinovana terapija sa antitumorskim alkaloidima | |
| JP2017516802A5 (https=) | ||
| JP2020523356A5 (https=) | ||
| RU2008152341A (ru) | Применение аллопуринола для лечения ладонно-подошвенной эритродизестезии | |
| HRP20250113T1 (hr) | Režim doziranja za gp100-specifični tcr - anti-cd3 scfv fuzijski protein | |
| JP2024516795A5 (https=) | ||
| JP2019530706A5 (https=) | ||
| JP2017537927A5 (https=) | ||
| JP2015522015A5 (https=) | ||
| JP2024016209A5 (https=) | ||
| JPWO2020250915A5 (https=) | ||
| RU2005126819A (ru) | Усовершенствованное лечение опухолей | |
| JP2016505050A5 (https=) | ||
| Katsumata | Dose-dense approaches to ovarian cancer treatment |